Charles River Laboratories reported strong second-quarter results, with revenue of $914.6 million, a 34.0% increase year-over-year. GAAP earnings per share were $1.72, and non-GAAP earnings per share were $2.61. The company also increased its 2021 financial guidance due to sustained demand.
Second-quarter revenue was $914.6 million.
Second-quarter GAAP earnings per share were $1.72.
Second-quarter non-GAAP earnings per share were $2.61.
The company increased its 2021 financial guidance.
The Company is increasing its 2021 financial guidance, which was previously provided on May 4, 2021, primarily as a result of the stronger-than-expected second-quarter financial performance and an expectation that robust client demand trends will continue for the remainder of the year.
Visualization of income flow from segment revenue to net income